| ID | 1391 | |
| PMID | 20089796 | |
| Year | 2010 | |
| Sequence | APQIPPNWHIPSIQDA ATPYHPPATPNNMGL | |
| Name | HSV-1 gD 287-317 (group-2) | |
| Length | 31 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | Intranasal immunizations with group 2 peptides induced strong CD4+ T cell proliferation in the conjunctiva. | |
| Mechanism | Not mentioned | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | FACS | |
| Enhancer | CpG adjuvant | |
| Properties of enhancer | Not mentioned | |
| Concentration | 50 µl per nasal cavity | |
| Incubation time | Immunized on 0,14 and 21 days. Euthanized after 10 days. | |
| Tissue permeability (value with units) | Detectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels | |
| Tissue Sample | Nasal cavity of New Zealand White rabbits | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N2[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]5[C@H](OCCC5) N[C@H](C(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@H](C(=O)N [C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C=O) CC(C)C)CCSC)CC(=O)N)CC(=O)N)CCC5)[C@H] (O)C)C)CCC)Cc5[nH]cnc5)Cc5ccc(cc5)O) CCC)[C@H](O)C)C)C)CC(=O)O)CCC(=O)N) [C@H](CC)C)CO)CCC4)[C@H](CC)C)Cc4[nH]cnc4)Cc4c [nH]c5c4cccc5)CC(=O)N)CCC3)CCC2) [C@H](CC)C)CCC(=O)N)CCC1)C | |